BROCK SOLOMON: Open Payments
NPI 1982931101 · LEWISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,643 in 92 payments from 17 companies in 2025. Trend: 2023 $1,468 · 2024 $2,014 · 2025 $1,643
Food & beverage: $1,643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $385 |
| Novo Nordisk Inc | 20 | $339 |
| AstraZeneca Pharmaceuticals LP | 13 | $276 |
| PFIZER INC. | 7 | $128 |
| Lilly USA, LLC | 5 | $87 |
| Exact Sciences Corporation | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Abbott Laboratories | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
Products named: QULIPTA, VRAYLAR, BREZTRI, Ozempic, Wegovy, Rybelsus, MOUNJARO, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
